DK1901736T3 - Farmaceutisk sammensætning omfattende simvastatin og ezetimib - Google Patents
Farmaceutisk sammensætning omfattende simvastatin og ezetimibInfo
- Publication number
- DK1901736T3 DK1901736T3 DK06762303.3T DK06762303T DK1901736T3 DK 1901736 T3 DK1901736 T3 DK 1901736T3 DK 06762303 T DK06762303 T DK 06762303T DK 1901736 T3 DK1901736 T3 DK 1901736T3
- Authority
- DK
- Denmark
- Prior art keywords
- ezetimibe
- simvastatin
- pharmaceutical composition
- oxygen
- present
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Dental Preparations (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05014680A EP1741427A1 (en) | 2005-07-06 | 2005-07-06 | Pharmaceutical composition comprising simvastatin and ezetimibe |
PCT/EP2006/006369 WO2007003365A1 (en) | 2005-07-06 | 2006-06-30 | Pharmaceutical composition comprising simvastatin and ezetimibe |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1901736T3 true DK1901736T3 (da) | 2010-08-16 |
Family
ID=34937786
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK06762303.3T DK1901736T3 (da) | 2005-07-06 | 2006-06-30 | Farmaceutisk sammensætning omfattende simvastatin og ezetimib |
Country Status (17)
Country | Link |
---|---|
US (1) | US8921352B2 (da) |
EP (2) | EP1741427A1 (da) |
AT (1) | ATE464882T1 (da) |
CA (1) | CA2614347A1 (da) |
DE (1) | DE602006013821D1 (da) |
DK (1) | DK1901736T3 (da) |
EA (1) | EA013266B1 (da) |
ES (1) | ES2341731T3 (da) |
HR (1) | HRP20100282T1 (da) |
NO (1) | NO340496B1 (da) |
PL (1) | PL1901736T3 (da) |
PT (1) | PT1901736E (da) |
RS (1) | RS51338B (da) |
SI (1) | SI1901736T1 (da) |
UA (1) | UA90521C2 (da) |
WO (1) | WO2007003365A1 (da) |
ZA (1) | ZA200800111B (da) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005061452A1 (en) | 2003-12-23 | 2005-07-07 | Astrazeneca Ab | Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity |
UY29607A1 (es) | 2005-06-20 | 2007-01-31 | Astrazeneca Ab | Compuestos quimicos |
SA06270191B1 (ar) | 2005-06-22 | 2010-03-29 | استرازينيكا ايه بي | مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم |
MY148538A (en) | 2005-06-22 | 2013-04-30 | Astrazeneca Ab | Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions |
TW200811098A (en) | 2006-04-27 | 2008-03-01 | Astrazeneca Ab | Chemical compounds |
WO2008101723A2 (en) * | 2007-02-23 | 2008-08-28 | Krka | Pharmaceutical composition containing a cholesterol absorption inhibitor |
WO2009024889A2 (en) * | 2007-08-21 | 2009-02-26 | Ranbaxy Laboratories Limited | Pharmaceutical composition comprising a hmg-coa reductase inhibitor and ezetimibe |
UA103179C2 (ru) | 2007-12-10 | 2013-09-25 | Ратиофарм Гмбх | Фармацевтическая композиция, которая содержит эзетимиб |
WO2009077573A2 (en) * | 2007-12-17 | 2009-06-25 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Suspension comprising non-micronized ezetimibe micro-particles |
TR200806302A2 (tr) * | 2008-08-22 | 2010-03-22 | Bi̇lgi̇ç Mahmut | Çözünürlük ve stabilite artırıcı farmasötik formülasyon. |
TR200806300A2 (tr) * | 2008-08-22 | 2010-03-22 | B�Lg�� Mahmut | Çözünürlük artırıcı farmasötlk formulasyon |
MX344885B (es) * | 2008-11-10 | 2017-01-10 | Psicofarma S A De C V | Proceso para la obtencion de una composicion de rosuvastatina calcica y producto obtenido. |
EP2204170A1 (en) | 2008-12-01 | 2010-07-07 | LEK Pharmaceuticals D.D. | Pharmaceutical composition comprising ezetimibe and simvastatin |
EP2216016A1 (en) | 2009-02-06 | 2010-08-11 | LEK Pharmaceuticals d.d. | Process for the preparation of a pharmaceutical composition comprising ezetimibe |
EP2448919A2 (en) * | 2009-07-02 | 2012-05-09 | Mahmut Bilgic | Solubility and stability enchancing pharmaceutical formulation |
WO2011002424A2 (en) | 2009-07-02 | 2011-01-06 | Bilgic Mahmut | Solubility and stability enchancing pharmaceutical formulation |
WO2011002422A2 (en) * | 2009-07-02 | 2011-01-06 | Bilgic Mahmut | Solubility enhancing pharmaceutical formulation |
EP2368543A1 (en) | 2010-03-25 | 2011-09-28 | KRKA, tovarna zdravil, d.d., Novo mesto | Method of preparing a granulated pharmaceutical composition comprising simvastatin and/or ezetimibe |
EP2468258A1 (en) | 2010-12-22 | 2012-06-27 | LEK Pharmaceuticals d.d. | Process for the preparation of a pharmaceutical composition comprising a low soluble pharmaceutically active ingredient |
AR086675A1 (es) * | 2011-06-14 | 2014-01-15 | Merck Sharp & Dohme | Composiciones farmaceuticas de combinaciones de inhibidores de la dipeptidil peptidasa-4 con simvastatina |
CN102266323B (zh) * | 2011-08-04 | 2013-03-27 | 海南锦瑞制药股份有限公司 | 依折麦布和辛伐他汀组合物及其制备方法 |
KR102578578B1 (ko) * | 2016-02-03 | 2023-09-14 | 삼성전자주식회사 | 암모니아수 내의 불순물 검출방법 |
JP7115825B2 (ja) * | 2017-06-28 | 2022-08-09 | 日医工株式会社 | エゼチミブ含有経口製剤及びその製造方法 |
JP2019014700A (ja) * | 2017-07-11 | 2019-01-31 | 大原薬品工業株式会社 | エゼチミブ含有口腔内崩壊錠及びその製造方法 |
FR3069545B1 (fr) * | 2017-07-27 | 2020-10-16 | Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic | Composition d'enrobage exempte de dioxyde de titane |
PL425975A1 (pl) * | 2018-06-19 | 2020-01-02 | Invest Bielany Spółka Z Ograniczoną Odpowiedzialnością | Złożona kompozycja farmaceutyczna do leczenia dyslipidemii i sposób jej wytwarzania |
EP4188338A1 (en) * | 2020-07-27 | 2023-06-07 | KRKA, d.d., Novo mesto | Bilayer tablet comprising ezetimibe and atorvastatin |
CN115227659B (zh) * | 2022-08-19 | 2023-05-02 | 北京百奥药业有限责任公司 | 一种依折麦布辛伐他汀组合物及其制备方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU548996B2 (en) | 1980-02-04 | 1986-01-09 | Merck & Co., Inc. | Tetrahydro-2h-pyran-2-one derivatives |
US4820850A (en) | 1987-07-10 | 1989-04-11 | Merck & Co., Inc. | Process for α-C-alkylation of the 8-acyl group on mevinolin and analogs thereof |
US4916239A (en) | 1988-07-19 | 1990-04-10 | Merck & Co., Inc. | Process for the lactonization of mevinic acids and analogs thereof |
US5631365A (en) * | 1993-09-21 | 1997-05-20 | Schering Corporation | Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
US6235311B1 (en) * | 1998-03-18 | 2001-05-22 | Bristol-Myers Squibb Company | Pharmaceutical composition containing a combination of a statin and aspirin and method |
EP1413331B1 (en) * | 2001-01-26 | 2007-10-03 | Schering Corporation | Combinations of the peroxisome proliferator-activated receptor (PPAR) activator fenofibrate with sterol absorption inhibitor ezetimibe for vascular indications |
EP1241110A1 (en) * | 2001-03-16 | 2002-09-18 | Pfizer Products Inc. | Dispensing unit for oxygen-sensitive drugs |
US6669955B2 (en) * | 2001-08-28 | 2003-12-30 | Longwood Pharmaceutical Research, Inc. | Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin |
US20030153617A1 (en) * | 2001-12-18 | 2003-08-14 | Dalen Frans Van | Simvastatin dosage forms |
AR040588A1 (es) * | 2002-07-26 | 2005-04-13 | Schering Corp | Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa |
SI21400A (sl) * | 2003-02-12 | 2004-08-31 | LEK farmacevtska družba d.d. | Stabilna farmacevtska oblika z inhibitorjem HMG-CoA reduktaze |
AU2003259547A1 (en) | 2003-07-31 | 2005-02-14 | Hetero Drugs Limited | Ezetimibe polymorphs |
PL379195A1 (pl) * | 2003-08-05 | 2006-07-24 | Zentiva, A.S. | Sposoby stabilizacji atorwastatyny |
US20060223882A1 (en) * | 2005-03-23 | 2006-10-05 | Venkataraman Sundaram | Amorphous simvastatin |
-
2005
- 2005-07-06 EP EP05014680A patent/EP1741427A1/en not_active Withdrawn
-
2006
- 2006-06-30 AT AT06762303T patent/ATE464882T1/de active
- 2006-06-30 ES ES06762303T patent/ES2341731T3/es active Active
- 2006-06-30 RS RSP-2010/0213A patent/RS51338B/en unknown
- 2006-06-30 EA EA200702416A patent/EA013266B1/ru not_active IP Right Cessation
- 2006-06-30 UA UAA200714923A patent/UA90521C2/uk unknown
- 2006-06-30 SI SI200630707T patent/SI1901736T1/sl unknown
- 2006-06-30 PT PT06762303T patent/PT1901736E/pt unknown
- 2006-06-30 DK DK06762303.3T patent/DK1901736T3/da active
- 2006-06-30 US US11/994,782 patent/US8921352B2/en not_active Expired - Fee Related
- 2006-06-30 EP EP06762303A patent/EP1901736B1/en active Active
- 2006-06-30 WO PCT/EP2006/006369 patent/WO2007003365A1/en active Application Filing
- 2006-06-30 CA CA002614347A patent/CA2614347A1/en not_active Abandoned
- 2006-06-30 PL PL06762303T patent/PL1901736T3/pl unknown
- 2006-06-30 DE DE602006013821T patent/DE602006013821D1/de active Active
-
2008
- 2008-01-04 ZA ZA200800111A patent/ZA200800111B/xx unknown
- 2008-02-04 NO NO20080627A patent/NO340496B1/no not_active IP Right Cessation
-
2010
- 2010-05-21 HR HR20100282T patent/HRP20100282T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
SI1901736T1 (sl) | 2010-08-31 |
NO340496B1 (no) | 2017-05-02 |
US8921352B2 (en) | 2014-12-30 |
ZA200800111B (en) | 2008-12-31 |
ES2341731T3 (es) | 2010-06-25 |
CA2614347A1 (en) | 2007-01-11 |
ATE464882T1 (de) | 2010-05-15 |
PT1901736E (pt) | 2010-05-31 |
RS51338B (en) | 2011-02-28 |
US20080300233A1 (en) | 2008-12-04 |
EA200702416A1 (ru) | 2008-04-28 |
DE602006013821D1 (en) | 2010-06-02 |
EP1741427A1 (en) | 2007-01-10 |
EP1901736A1 (en) | 2008-03-26 |
HRP20100282T1 (hr) | 2010-07-31 |
EP1901736B1 (en) | 2010-04-21 |
EA013266B1 (ru) | 2010-04-30 |
PL1901736T3 (pl) | 2010-09-30 |
NO20080627L (no) | 2008-04-02 |
UA90521C2 (uk) | 2010-05-11 |
WO2007003365A1 (en) | 2007-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1901736T3 (da) | Farmaceutisk sammensætning omfattende simvastatin og ezetimib | |
EA201390409A1 (ru) | Составы с низкой дозой панкрелипазы и кишечно-растворимым покрытием | |
JP2010532765A5 (da) | ||
BR0314612A (pt) | Composição farmacêutica estabilizada, contendo excipientes básicos | |
WO2007051811A3 (en) | Pharmaceutical use of substituted amides | |
EA200870216A1 (ru) | Амидо соединения и их применение в качестве лекарственных средств | |
BRPI0414581B8 (pt) | composto, composição farmacêutica compreendendo o referido composto e uso do referido composto | |
ATE470443T1 (de) | Indol-1-yl-essigsäurederivate | |
MY147373A (en) | Piperazine derivatives as antimalarial agents | |
EA200970081A1 (ru) | Соединения, обладающие потенциирующим действием в отношении активности этионамида, и их применения | |
ATE486587T1 (de) | Formulierungen zur oralen verabreichung von wirkstoffen | |
HK1084582A1 (en) | Stable solid medicinal composition for oral administration | |
EA201100430A1 (ru) | Стабильная комбинированная фармацевтическая композиция | |
PT1414467E (pt) | Tratamento topico da mastalgia | |
TW200736203A (en) | New pleuromutilin derivative and its use | |
EP2801359A3 (en) | The use of nicotine for the treatment of sepsis in humans caused by antibiotic | |
ATE460934T1 (de) | Pharmazeutische zubereitungen von ciprofloxacin | |
CY1120050T1 (el) | Φαρμακοτεχνικες μορφες για την αποδεσμευση δραστικων ενωσεων | |
EA201100104A1 (ru) | Фармацевтическая композиция, содержащая статин | |
EA201290485A1 (ru) | Производные бензамида | |
EP1713439B1 (en) | Pharmaceutical preparation for the oral cavity | |
RU2006109966A (ru) | Препарат "янтастим-с" для терапии и профилактики инфекционных заболеваний животных | |
BRPI0407529A (pt) | uso de r-10-hidróxi-10,11-dihidro-carbamazepina em dor neuropática | |
CY1110814T1 (el) | Νεα υποκατεστημενα αρυλοεξαδιενικα οξεα και εστερες αυτων τα οποια μπορουν να χρησιμοποιηθουν για την αγωγη και προληψη του διαβητη, δυσλιπιδαιμιας και αθηροσκληρωσης, φαρμακευτικες συνθεσεις που τα περιλαμβανουν και διεργασιες για την παρασκευη αυτων | |
AU2016219620A1 (en) | Compositions and methods useful for treatment of respiratory illness |